Monthly Archives: May 2017

Handholding young scientists in a country fraught with infection burden, climate change and health consequences


With many people in Bangladesh migrating from coastal areas to cities, the country must deal with ever increasing healthcare challenges. In an effort to deliver health care innovations, the International Centre for Diarrheal Diseases Research Bangladesh (icddr,b) is charting a career plan for its young scientists. To tell us more about this ambitious plan for handholding and nurturing young scientists, is Niyaz Ahmed, Senior Director of Laboratory Sciences and Services Division at the icddr,b and Editor-in-Chief of Gut Pathogens.


Use hepatitis C elimination to fund harm reduction – and vice versa


The aim of the European Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) is to help eliminate HIV and reduce viral hepatitis and TB among people who inject drugs (PWID) in the European Union by 2020. HA-REACT focuses on member states with gaps in effective, evidence-informed interventions. The Joint Action also encourages the implementation of comprehensive harm-reduction programmes throughout the EU as an essential strategy for improving the prevention and treatment of HIV, viral hepatitis and TB.